Orthopaedics sector shines
This article was originally published in Clinica
Executive Summary
Abbott Laboratories' diagnostic sales were $721 million in the quarter, down 4% on the previous year's second quarter. US hospital products sales were up 4% at $686 million, while international hospital products were $190 million, down slightly. The effects of foreign exchange continue to hit figures. The company says its diagnostic sales are expected to accelerate during the remainder of the year, with double-digit growth predicted in the fourth quarter. Growth rates for US hospital products in the second half and full year are similarly expected to be in double digits.